Inkjet actuator substrate having at least one non-uniform ink via
    4.
    发明申请
    Inkjet actuator substrate having at least one non-uniform ink via 审中-公开
    具有至少一个非均匀油墨通孔的喷墨致动器基板

    公开(公告)号:US20070176982A1

    公开(公告)日:2007-08-02

    申请号:US11345092

    申请日:2006-02-01

    IPC分类号: B41J2/175

    摘要: Inkjet printheads and actuator chips, such as an inkjet printhead actuator chip having a substrate, ink vias formed in the substrate, and columnar arrays of actuators in operational communication with the ink vias. At least one of the ink vias has at least one of a different length, width and a via to via pitch than another one of the ink vias. Imaging devices for use with the printheads are also disclosed.

    摘要翻译: 喷墨打印头和致动器芯片,例如具有基板的喷墨打印头致动器芯片,形成在基板中的油墨通孔和与油墨通孔操作连通的致动器柱状阵列。 油墨通孔中的至少一个具有与另一个墨通孔不同的长度,宽度和通孔间距中的至少一个。 还公开了与打印头一起使用的成像装置。

    Ink jet print head adapted to minimize orientation-induced line-width variation
    5.
    发明申请
    Ink jet print head adapted to minimize orientation-induced line-width variation 有权
    喷墨打印头适于最小化定向引起的线宽变化

    公开(公告)号:US20070153055A1

    公开(公告)日:2007-07-05

    申请号:US11323433

    申请日:2005-12-30

    申请人: James Powers

    发明人: James Powers

    IPC分类号: B41J2/16

    CPC分类号: B41J2/145 B41J2/1433

    摘要: Ink jet print head adapted to minimize orientation-induced line-width variation. The print head having n nozzles located at the vertices of a regular or quasi-regular polygon having an average side length savg, and each side length of the polygon is less than 20% deviation from the average side length savg. The n nozzles are configured to ink jet a line having a line-width w; and each of the n nozzles is configured to ink jet a spot having an average area-equivalent spot diameter d which satisfies the inequality condition (I) 0.7w≦d+(n/π)savg

    摘要翻译: 喷墨打印头适于最小化定向引起的线宽变化。 具有位于具有平均侧面长度s平均值的正常或准正多边形的顶点的n个喷嘴的打印头和多边形的每个边长小于平均侧的偏差的20% 长度s平均值。 n个喷嘴构造成喷墨具有线宽w的线; 并且n个喷嘴中的每一个被配置为喷射具有满足不等式条件(I)的平均面积当量光斑直径d的斑点<?in-line-formula description =“In-line Formulas”end =“lead” α> 0.7w <= D +(n / pi)s <1.3w(I)<?in-line-formula description =“In-line Formulas”end =“tail”?>

    Radiation stability of polymer pellicles
    6.
    发明申请
    Radiation stability of polymer pellicles 失效
    聚合物薄膜的辐射稳定性

    公开(公告)号:US20060234134A1

    公开(公告)日:2006-10-19

    申请号:US10611070

    申请日:2003-06-30

    IPC分类号: A47G1/12 G03F1/14 G03F1/00

    CPC分类号: G03F1/62

    摘要: An embodiment of the present invention includes a technique to improve stability of a pellicle. The pellicle is pre-baked at a predetermined temperature substantially below a glass transition temperature. The pre-baked pellicle is purged with an inert gas. The purged pellicle is radiated by a radiation at a wavelength. In another embodiment, a chamber is sealed with a pellicle membrane which divides the chamber into first and second compartments. The chamber has an inflow opening in the first compartment and an outflow opening in the second compartment. A gas is injected into the inflow opening and penetrates the pellicle membrane to the outflow opening. In another embodiment, the chamber has first inflow and outflow openings and second inflow and outflow openings in the first and second compartments, respectively. A first gas is injected into the first inflow opening and a second gas into the second inflow opening. The first and second gases have a permeability difference. The first gas penetrates the pellicle membrane to the second outflow opening.

    摘要翻译: 本发明的一个实施例包括提高防护薄膜的稳定性的技术。 防护薄膜组件在基本上低于玻璃化转变温度的预定温度下预烘烤。 预烘烤的防护薄膜组件用惰性气体吹扫。 被吹扫的防护薄膜组件以波长的辐射辐射。 在另一个实施例中,用隔热膜密封腔室,隔膜膜将腔室分成第一和第二隔室。 所述腔室在第一隔室中具有流入开口,并且在第二隔室中具有流出开口。 将气体注入到流入口中并将防护薄膜穿透到流出口。 在另一个实施例中,腔室分别具有第一和第二隔室中的第一流入口和第二流入口和第二流入口。 将第一气体注入第一流入口,将第二气体注入第二流入口。 第一和第二气体具有渗透率差异。 第一气体将防护薄膜穿入第二流出口。

    Security barrier reinforcing system
    7.
    发明授权
    Security barrier reinforcing system 有权
    安全防护加强系统

    公开(公告)号:US07121041B2

    公开(公告)日:2006-10-17

    申请号:US10777932

    申请日:2004-02-12

    IPC分类号: E01F13/00

    CPC分类号: E01F13/048

    摘要: A system for upgrading new and existing gates or barriers to provide improved crash barrier rating. This system comprises a reinforcing attachment to the gate or barrier and improved reinforced bollards with catch hooks to absorb the energy of impact from a vehicle. The reinforcing attachment is an arrangement of cable and structural members that provide for increased reinforcement by ensuring that the load is distributed on the cable to minimize the risk of breakthrough as a result of cable failure. The bollards have been improved by strengthening the catch hook attachments and adding reinforcement positioning elements to facilitate proper assembly.

    摘要翻译: 一种升级新的和现有的闸门或障碍物以提高防撞等级的系统。 该系统包括对闸门或障碍物的加强附件以及具有抓钩的改进的加固护柱,以吸收来自车辆的冲击能量。 加强附件是电缆和结构构件的布置,其通过确保负载分布在电缆上以最小化由于电缆故障导致的突破的风险而提供增强的加强。 通过加强挂钩附件并增加加固定位元件以便于正确的组装,护柱已得到改进。

    Aza-peptide epoxides
    8.
    发明申请
    Aza-peptide epoxides 有权
    氮杂肽环氧化物

    公开(公告)号:US20060172952A1

    公开(公告)日:2006-08-03

    申请号:US11338147

    申请日:2006-01-24

    摘要: Methods for treatment and/or prevention of nerve degeneration in mammals using aza-peptide epoxide caspase inhibitors are provided. Aspects of the present disclosure include aza-peptide epoxide compositions to treat or prevent diseases, for example stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathies, Huntington's disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophies, spinal bulbar muscular atrophy, diabetes, amyotrophic lateral sclerosis and other motor neuron diseases. The disclosed methods can be used in combination with calpain inhibitors to treat disease or pathological conditions related to the activity of caspases and calpain associated with a specific disease or condition. Such treatable conditions include stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathies, Huntington's disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophies, spinal bulbar muscular atrophy, nerve degeneration associated with diabetes, amyotrophic lateral sclerosis and other motor neuron diseases, nerve degeneration secondary to primary demyelinating disorders, among others.

    摘要翻译: 提供了使用氮杂 - 环氧化物半胱天冬酶抑制剂治疗和/或预防哺乳动物神经变性的方法。 本公开的方面包括治疗或预防疾病,例如中风,阿尔茨海默氏病,帕金森病,多发性硬化,神经病,亨廷顿舞蹈病,齿状萎缩性萎缩症,脊髓小脑萎缩症,脊髓扩张肌肉萎缩症,糖尿病,肌萎缩性侧索的氮杂肽环氧化物组合物 硬化症等运动神经元疾病。 所公开的方法可以与钙蛋白酶抑制剂组合使用以治疗与特定疾病或病症相关的胱天蛋白酶和钙蛋白酶的活性相关的疾病或病理状况。 这种可治疗的病症包括中风,阿尔茨海默氏病,帕金森病,多发性硬化症,神经病,亨廷顿舞蹈病,齿状萎缩性萎缩症,脊髓小脑萎缩,脊髓延髓肌肉萎缩,与糖尿病相关的神经变性,肌萎缩性侧索硬化等运动神经元疾病,继发于神经变性 原发性脱髓鞘疾病等。